Publication Information

{'id': 'https://openalex.org/W2153127526', 'doi': 'https://doi.org/10.1345/aph.1g120', 'title': 'Cangrelor for Treatment of Coronary Thrombosis', 'display_name': 'Cangrelor for Treatment of Coronary Thrombosis', 'publication_year': 2006, 'publication_date': '2006-04-05', 'ids': {'openalex': 'https://openalex.org/W2153127526', 'doi': 'https://doi.org/10.1345/aph.1g120', 'mag': '2153127526', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/16595568'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1345/aph.1g120', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S113426163', 'display_name': 'Annals of Pharmacotherapy', 'issn_l': '1060-0280', 'issn': ['1060-0280', '1542-6270'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5077993290', 'display_name': 'Susan E. Fugate', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}, {'id': 'https://openalex.org/I27253931', 'display_name': 'Oklahoma City University', 'ror': 'https://ror.org/02bs0cv29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I27253931']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Susan E Fugate', 'raw_affiliation_strings': ['College of Pharmacy, University of Oklahoma, Oklahoma City, OK'], 'affiliations': [{'raw_affiliation_string': 'College of Pharmacy, University of Oklahoma, Oklahoma City, OK', 'institution_ids': ['https://openalex.org/I8692664', 'https://openalex.org/I27253931']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5033393262', 'display_name': 'Laura A. Cudd', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I27253931', 'display_name': 'Oklahoma City University', 'ror': 'https://ror.org/02bs0cv29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I27253931']}, {'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Laura A Cudd', 'raw_affiliation_strings': ['College of Pharmacy, University of Oklahoma, Oklahoma City, OK'], 'affiliations': [{'raw_affiliation_string': 'College of Pharmacy, University of Oklahoma, Oklahoma City, OK', 'institution_ids': ['https://openalex.org/I27253931', 'https://openalex.org/I8692664']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.176, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 55, 'citation_normalized_percentile': {'value': 0.611235, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '40', 'issue': '5', 'first_page': '925', 'last_page': '930'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy and Cardiovascular Diseases', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy and Cardiovascular Diseases', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10292', 'display_name': 'Acute Myocardial Infarction Research', 'score': 0.9972, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10285', 'display_name': 'Venous Thromboembolism Diagnosis and Management', 'score': 0.9954, 'subfield': {'id': 'https://openalex.org/subfields/2724', 'display_name': 'Internal Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cangrelor', 'display_name': 'Cangrelor', 'score': 0.9887635}, {'id': 'https://openalex.org/keywords/pharmacodynamics', 'display_name': 'Pharmacodynamics', 'score': 0.43203577}], 'concepts': [{'id': 'https://openalex.org/C2776708134', 'wikidata': 'https://www.wikidata.org/wiki/Q3655338', 'display_name': 'Cangrelor', 'level': 5, 'score': 0.9887635}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8889137}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.6064204}, {'id': 'https://openalex.org/C2777288759', 'wikidata': 'https://www.wikidata.org/wiki/Q4164182', 'display_name': 'Dosing', 'level': 2, 'score': 0.5703636}, {'id': 'https://openalex.org/C49059817', 'wikidata': 'https://www.wikidata.org/wiki/Q14916330', 'display_name': 'P2Y12', 'level': 4, 'score': 0.5695036}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.51845425}, {'id': 'https://openalex.org/C2777849778', 'wikidata': 'https://www.wikidata.org/wiki/Q410237', 'display_name': 'Clopidogrel', 'level': 3, 'score': 0.4867244}, {'id': 'https://openalex.org/C111113717', 'wikidata': 'https://www.wikidata.org/wiki/Q725307', 'display_name': 'Pharmacodynamics', 'level': 3, 'score': 0.43203577}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.38621396}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3373909}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.23832491}, {'id': 'https://openalex.org/C2777628954', 'wikidata': 'https://www.wikidata.org/wiki/Q18216', 'display_name': 'Aspirin', 'level': 2, 'score': 0.21459284}], 'mesh': [{'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D003328', 'descriptor_name': 'Coronary Thrombosis', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D058919', 'descriptor_name': 'Purinergic P2 Receptor Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003328', 'descriptor_name': 'Coronary Thrombosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1345/aph.1g120', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S113426163', 'display_name': 'Annals of Pharmacotherapy', 'issn_l': '1060-0280', 'issn': ['1060-0280', '1542-6270'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16595568', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.62}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 20, 'referenced_works': ['https://openalex.org/W1935279647', 'https://openalex.org/W1939515787', 'https://openalex.org/W1944642365', 'https://openalex.org/W1986775812', 'https://openalex.org/W1988121084', 'https://openalex.org/W1993323415', 'https://openalex.org/W2024237851', 'https://openalex.org/W2035816283', 'https://openalex.org/W2039496408', 'https://openalex.org/W2060231998', 'https://openalex.org/W2060258953', 'https://openalex.org/W2084065232', 'https://openalex.org/W2085548132', 'https://openalex.org/W2110489891', 'https://openalex.org/W2125093797', 'https://openalex.org/W2131128772', 'https://openalex.org/W2135570570', 'https://openalex.org/W2147629768', 'https://openalex.org/W2160457934', 'https://openalex.org/W2163170969'], 'related_works': ['https://openalex.org/W3095930157', 'https://openalex.org/W2786129852', 'https://openalex.org/W2552628467', 'https://openalex.org/W2551205994', 'https://openalex.org/W2395455044', 'https://openalex.org/W2136228924', 'https://openalex.org/W2096379851', 'https://openalex.org/W2010454652', 'https://openalex.org/W1981329287', 'https://openalex.org/W1973911240'], 'abstract_inverted_index': {'To': [0], 'review': [1, 95], 'and': [2, 20, 22, 46, 60, 80, 94, 133, 135, 150, 176, 196], 'assess': [3], 'available': [4], 'literature': [5, 35], 'on': [6, 193], 'the': [7, 200], 'chemistry,': [8], 'pharmacology,': [9], 'pharmacodynamics,': [10], 'pharmacokinetics,': [11], 'clinical': [12, 33, 92, 194], 'studies,': [13, 91], 'adverse': [14], 'events,': [15], 'drug': [16], 'interactions,': [17], 'special': [18], 'populations,': [19], 'dosing': [21], 'administration': [23], 'for': [24, 70, 105, 140, 160], 'cangrelor,': [25, 58], 'a': [26, 81, 100, 156, 177], 'product': [27], 'in': [28, 119, 165], 'late': [29], 'stage': [30], 'Phase': [31, 144, 170, 185], 'II': [32, 145, 171], 'trials.A': [34], 'search': [36], 'of': [37, 57, 65, 107, 121, 152, 162, 180, 202], 'MEDLINE': [38], '(1966-March': [39], '2006),': [40, 45], 'International': [41], 'Pharmaceutical': [42], 'Abstracts': [43], '(1970-February': [44], 'Cochrane': [47], 'database': [48], '(first': [49], 'quarter': [50], '2006)': [51], 'was': [52, 78, 84, 97], 'conducted': [53], 'using': [54], 'key': [55], 'terms': [56], 'AR-C69931MX,': [59], 'P2Y12': [61, 101], 'receptor': [62], 'antagonist.': [63], 'Bibliographies': [64], 'relevant': [66], 'articles': [67], 'were': [68], 'reviewed': [69], 'additional': [71], 'references.': [72], 'The': [73], 'Medicines': [74], 'Company': [75], 'Web': [76], 'site': [77], 'reviewed,': [79], 'company': [82], 'representative': [83], 'contacted.Available': [85], 'English-language': [86], 'literature,': [87], 'including': [88], 'abstracts,': [89], 'preclinical': [90], 'trials,': [93], 'articles,': [96], 'reviewed.Cangrelor': [98], 'is': [99, 155, 204], 'antagonist': [102], 'under': [103], 'development': [104], 'treatment': [106], 'acute': [108, 166], 'coronary': [109, 168], 'syndrome.': [110], 'Cangrelor': [111], 'has': [112], 'been': [113], 'studied': [114], 'as': [115], 'an': [116], 'intravenous': [117], 'infusion': [118], 'doses': [120], '2': [122], 'or': [123], '4': [124], 'microg/kg/min.': [125], 'It': [126], 'inhibits': [127], 'platelet': [128, 153, 163, 181], 'aggregation': [129, 164, 182], 'with': [130], 'rapid': [131], 'onset': [132], 'offset': [134], 'does': [136], 'not': [137], 'require': [138], 'metabolism': [139], 'therapeutic': [141], 'activity.': [142], 'Published': [143], 'trials': [146, 172, 187], 'have': [147, 173], 'demonstrated': [148], 'safety': [149, 175], 'inhibition': [151, 161, 179], 'aggregation.Cangrelor': [154], 'promising': [157], 'investigational': [158], 'medication': [159], 'arterial': [167], 'events.': [169], 'shown': [174], 'greater': [178], 'over': [183], 'clopidogrel.': [184], 'III': [186], 'will': [188], 'provide': [189], 'more': [190], 'definitive': [191], 'information': [192], 'efficacy': [195], 'safety.': [197], 'Until': [198], 'then,': [199], 'role': [201], 'cangrelor': [203], 'uncertain.': [205]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2153127526', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 5}], 'updated_date': '2024-12-13T01:54:50.482623', 'created_date': '2016-06-24'}